107 related articles for article (PubMed ID: 30810086)
1. Potential anticancer activity and mechanism of action of nanoformulated curcumin in experimental Ehrlich ascites carcinoma-bearing animals.
El-Far M; Salah N; Essam A; Abd El-Azim A; Karam M; El-Sherbiny IM
Nanomedicine (Lond); 2019 Mar; 14(5):553-573. PubMed ID: 30810086
[TBL] [Abstract][Full Text] [Related]
2. Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich ascites carcinoma-bearing animals.
El-Far M; Salah N; Essam A; Abd El-Azim AO; El-Sherbiny IM
Nanomedicine (Lond); 2018 Aug; 13(15):1865-1858. PubMed ID: 30136915
[TBL] [Abstract][Full Text] [Related]
3. Physico-chemical properties of curcumin nanoparticles and its efficacy against Ehrlich ascites carcinoma.
Rageh MM; Abdelmoneam EA; Sharaky M; Mohamad EA
Sci Rep; 2023 Nov; 13(1):20637. PubMed ID: 38001124
[TBL] [Abstract][Full Text] [Related]
4. Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation.
El-Far YM; Zakaria MM; Gabr MM; El Gayar AM; Eissa LA; El-Sherbiny IM
Nanomedicine (Lond); 2017 Jul; 12(14):1689-1711. PubMed ID: 28635562
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.
Ferreira AK; Meneguelo R; Pereira A; Mendonça Filho O; Chierice GO; Maria DA
Anticancer Res; 2012 Jan; 32(1):95-104. PubMed ID: 22213293
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
Khwaja S; Fatima K; Hasanain M; Behera C; Kour A; Singh A; Luqman S; Sarkar J; Chanda D; Shanker K; Gupta AK; Mondhe DM; Negi AS
Eur J Med Chem; 2018 May; 151():51-61. PubMed ID: 29605808
[TBL] [Abstract][Full Text] [Related]
7. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
[TBL] [Abstract][Full Text] [Related]
8. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.
Kumari M; Ray L; Purohit MP; Patnaik S; Pant AB; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2017 Aug; 117():346-362. PubMed ID: 28499854
[TBL] [Abstract][Full Text] [Related]
9. Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.
Kumari M; Purohit MP; Patnaik S; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2018 Sep; 130():185-199. PubMed ID: 29969665
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice.
El-Azab M; Hishe H; Moustafa Y; El-Awady el-S
Eur J Pharmacol; 2011 Feb; 652(1-3):7-14. PubMed ID: 21114990
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing mice.
Liu W; Zhang Z; Lin G; Luo D; Chen H; Yang H; Liang J; Liu Y; Xie J; Su Z; Cao H
Food Funct; 2017 Sep; 8(9):3120-3129. PubMed ID: 28766664
[TBL] [Abstract][Full Text] [Related]
12. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
[TBL] [Abstract][Full Text] [Related]
13. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
14. Grape seeds and skin induce tumor growth inhibition via G1-phase arrest and apoptosis in mice inoculated with Ehrlich ascites carcinoma.
Badr El-Din NK; Ali DA; Abou-El-Magd RF
Nutrition; 2019 Feb; 58():100-109. PubMed ID: 30391688
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells.
Pal S; Choudhuri T; Chattopadhyay S; Bhattacharya A; Datta GK; Das T; Sa G
Biochem Biophys Res Commun; 2001 Nov; 288(3):658-65. PubMed ID: 11676493
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
19. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
20. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
